Skip to main content
Caplight Logo









CardioRenal

CardioRenal

Private
GrenobleHealthcare & Life Scienceshttps://cardio-renal.com

Last Round

Seed

Apr 4, 2022

Total Funding Raised

$3.7M

Company Overview

CardioRenal is a medical technology company that develops remote monitoring solutions for patients with chronic kidney and heart failure.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Telemedicine, Health IoT, Patient Engagement

Business Model

B2B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

remote patient monitoringRPMchronic kidney diseaseCKDpoint-of-care diagnosticsmicrofluidicsconnected medical devicetelemedicinedigital healthblood biomarker monitoringhome-based diagnosticsclinical decision supportmedtechhealth IoTpatient engagement platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CardioRenal Comparables

Compare CardioRenal with similar companies based on industry and business-model similarity.

CardioRenal comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kalium Health
91%
CreatSens Health
87%
KitechDx
86%

CardioRenal Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 4, 2022

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 4, 2022

    $3.7M raised in Seed round.

CardioRenal Filings

Explore SEC and related filing metadata, where available.

CardioRenal filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CardioRenal's valuation, stock price, and market status.

Is CardioRenal a public or private company?

CardioRenal is a private company.

What is the current stock price of CardioRenal?

CardioRenal is a private company with no public stock price. No recent secondary market data is available.

How much is CardioRenal worth (valuation)?

Valuation information for CardioRenal is not publicly available.

Can I buy CardioRenal stock?

CardioRenal shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CardioRenal's last funding round?

CardioRenal's most recent funding round was Seed on April 4, 2022.

Who are the main investors in CardioRenal?

Investor information for CardioRenal is not publicly disclosed.

Will CardioRenal IPO soon?

No public IPO plans have been announced for CardioRenal.

How can I track CardioRenal secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CardioRenal's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGrenoble
Employee Range1
Year Founded2013
Last FundingApr 4, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?